Clinical Trials Directory

Trials / Completed

CompletedNCT00783978

Surfactant Disorders and Chronic Lung Disease

Surfactant Disorders Associated With Chronic Lung Disease in Children.

Status
Completed
Phase
Study type
Observational
Enrollment
58 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
1 Month – 17 Years
Healthy volunteers
Not accepted

Summary

Interstitial lung diseases (ILD) in children represent a heterogeneous group of rare and not well defined disorders. Genetic abnormalities of surfactant proteins B (SFTPB) and more recently C (SFTPC) have been shown to be related to these pathologies. However, variability in the lung disease phenotype suggests the involvement of other surfactant-associated genes such as ABCA3 (ATP-binding cassette, sub-family A, member, 3). Thus, the aim of this project is: 1) to assess the prevalence of SFTPC mutation in children with chronic lung diseases, 2) to precise clinical and radiological features of children with SFTPC mutation, and 3) to identify environmental or genetic factors that may explain the extreme variability of this disease.

Detailed description

The first stage of this project will be to constitute a clinical, radiological, biological database of children (1 moth-17 years) with severe respiratory distress and/or an unexplained chronic ILD. Mutations in SFTPC, SFTPB and ABCA3 will be further identified by sequencing and documented with using the parents blood samples.

Conditions

Interventions

TypeNameDescription
OTHERwhole blood sample2 ml of whole blood for children 5 ml of whole blood for parents that will be used only if 1 mutation is found in children

Timeline

Start date
2009-09-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2008-11-03
Last updated
2012-11-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00783978. Inclusion in this directory is not an endorsement.